Matrix proteinase inhibition by Æ-941, a multifunctional antiangiogenic compound

Anticancer Research

Volumn 21, Issue 1 A, 2001, Pages 145-156

  Gingras, D ^a   Renaud, A ^a   Mousseau, N ^a   Beaulieu, E ^a   Kachra, Z ^a   Beliveau R ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

Author keywords

941; Angiogenesis; Elastinolytic inhibitory activity; Gelatinolytic inhibitory activity; Matrix metalloproteinase; Shark cartilage

Indexed keywords

AE 941; ANGIOGENESIS INHIBITOR; COLLAGENASE; COLLAGENASE 3; GELATINASE A; GELATINASE B; LEUKOCYTE ELASTASE; MACROPHAGE ELASTASE; MATRILYSIN; MATRIX METALLOPROTEINASE; PANCREATIC ELASTASE; TISSUE INHIBITOR OF METALLOPROTEINASE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; PRIORITY JOURNAL; PROTEIN DEGRADATION;

ANGIOGENESIS INHIBITORS; EXTRACELLULAR MATRIX PROTEINS; HUMANS; KINETICS; MATRIX METALLOPROTEINASES; SERINE ENDOPEPTIDASES; TISSUE EXTRACTS; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 0035060804     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Tumor interactions with the vasculature: Angiogenesis and tumor metastasis
2. Regulation of metalloproteinase expression in tumor invasion
3. Matrix metalloproteinases in angiogenesis: A moving target for therapeutic intervention
4. Physiological roles of matrix metalloproteinases: Implications for tumor growth and metastasis
5. Matrix metalloproteinases
6. Tissue inhibitors of metalloproteinases (TIMP) in invasion and proliferation
7. Interaction of 92-kDa collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenases and activation of the proenzyme with stromelysin
8. Preferential inhibition of 72- and 92-kDa gelatinases by tissue inhibitor of matrix metalloproteinase
9. Expression of tissue inhibitors of metalloproteinases: Negative regulators of human glioblastoma invasion in vivo
10. Collagenases and tissue inhibitors of metalloproteinases: A functional balance in tissue degradation
11. Morphological studies on the resistance of cartilage to invasion by osteosarcoma cells in vitro and in vivo
12. Resistance of cartilage to invasion
13. Inhibition of tumor angiogenesis mediated by cartilage
14. Isolation of a cartilage factor that inhibits tumor neovascularization
15. Control of tumor growth in animals by infusion of an angiogenesis inhibitor
16. Identification of an inhibitor of neovascularization from cartilage
17. A metalloproteinase inhibitor as an inhibitor of neovascularization
18. Isolation and characterization of an inhibitor of neovascularization from scapular chondrocytes
19. A cartilage-derived inhibitor of neovascularization and metalloproteinases
20. Troponin I is present in human cartilage and inhibits angiogenesis
21. Shark cartilage contains inhibitors of tumor angiogenesis
22. Inhibition of angiogenesis by oral ingestion of powdered shark cartilage in a rat model
23. Purification and partial amino acid sequence of bovine cartilage-derived collagenase inhibitor
24. A novel angiogenic inhibitor derived from Japanese shark cartilage (1). Extraction and estimation of inhibitory activities toward tumor and embryonic angiogenesis
25. Anti-proliferative activity of shark cartilage with and without tumor necrosis factor-alpha in human umbilical vein endothelium
26. Effect of U-995, a potent shark cartilage-derived angiogenesis inhibitor, on anti-angiogenesis and antitumor activities
27. Angiostatic activity of Neovastat (Æ-941) assessed by a semi-quantitative embryonic vascularization test
28. Æ-941, a new and specific VEGF antagonist?
29. In vitro and in vivo anti-tumor activity of Neovastat (Æ-941), an angiostatic agent derived from shark cartilage
30. Æ-941 (Neovastat): An inhibitor of angiogenesis with anti-cancer activity
31. Phase I/II clinical trials of escalating dose of Æ-941, an inhibitor of angiogenesis in patients with refractory lung cancer
32. The plasminogen-plasmin system in malignancy
33. Urokinase plasminogen activator and gelatinases are associated with membrane vesicles shed by human HT 1080 fibrosarcoma cells
34. Macrophage elastase
35. Purification of an angiogenesis inhibitor from culture medium conditioned by a human chondrosarcoma-derived chondrocytic cell line, HCS-2/8
36. Tumor cell collagenase and its inhibition by a cartilage derived protease inhibitor
37. Growth regulators in connective tissue. Systemic administration of an aortic extract inhibits tumor growth in mice
38. Cartilage-derived anti-tumor factor (CAFT) inhibits the proliferation of endothelial cells in culture
39. Variation with ageing and degeneration of the serine and cysteine proteinase inhibitors of human articular cartilage
40. Distribution of the secretory leukocyte proteinase inhibitor in human articular cartilage
41. Preferential inactivation of tissue inhibitor of metalloproteinases-1 that is bound to the precursor of matrix metalloproteinase 9 (progelatinase B) by human neutrophil elastase
42. Degradation of cartilage matrix proteoglycan by human neutrophils involves both elastase and cathepsin G
43. Activation of matrix metalloproteinase 3 (stromelysin) and matrix metalloproteinase 2 ('gelatinase') by human neutrophil elastase and cathepsin G
44. Expression and localization of macrophage elastase (matrix metalloproteinase-12) in abdominal aortic aneurysms
45. Elastase in tissue injury
46. Metastatic potential correlates with enzymatic degradation of basement membrane collagen
47. Metalloproteinases and cancer invasion
48. Type IV collagenases in tumor invasion and metastasis
49. Matrix metalloproteinases and tumor invasion: From correlation and causality to the clinic